DIABETES 911: Diagnosing and Managing Diabetic Ketoacidosis, Hyperglycemic Hyperosmolar State, and Hypoglycemia.

DIABETES 911: Diagnosing and Managing Diabetic Ketoacidosis, Hyperglycemic Hyperosmolar State, and Hypoglycemia

A series of Live Grand Rounds Presentations

Welcome to "DIABETES 911: Diagnosing and Managing Diabetic Ketoacidosis, Hyperglycemic Hyperosmolar State, and Hypoglycemia.” This CME-certified initiative is intended for physicians and other health care providers who manage patients with diabetes-related emergencies. A series of live CME-certified in-hospital presentations will be held at locations nationwide in 2016.

Program Description:

Diabetes mellitus (DM) emergencies, related to hypoglycemia and hyperglycemia, are frequent causes of visits to the emergency department (ED) and, in some cases, hospitalization. DM emergencies can also be life-threatening if not recognized and managed in a timely manner.

Diabetic ketoacidosis (DKA) is more commonly known as a complication associated with T1DM. However, DKA can also occur in patients with T2DM. The possible association between DKA and SGLT-2 inhibitors may increase the probability of seeing T2DM patients presenting with DKA. DIABETES 911 will inform DM care team clinicians, including those in the emergency department, of the presentations of DKA, specifically in T2DM patients, and will show how to differentiate this condition from a hyperosmolar hyperglycemic state (HHS) in patients presenting with a hyperglycemic crisis

Educational Objectives:

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Apply diagnostic criteria and recent clinical experience to improve the recognition of hyperglycemic emergencies, namely DKA and HHS
  • Evaluate the impact of the results from recent randomized control trials on the prevalence, risk factors, and consequences of antidiabetic therapy-induced hypoglycemia for the care of T2DM patients
  • Utilize guidelines and expert recommendations to manage patients with diabetes who present with hypoglycemic and hyperglycemic complications

Accreditation Statements:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Rockpointe. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statements:

The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.